References
- Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B. (2000). Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:1131–52.
- Capolongo F, Dacasto M, Carletti M, Nebbia C, Merlanti R, Montesissa C. (2003). Effetti di alcuni trattamenti illeciti sul metabolismo ossidativo P450-dipendente nel fegato del vitello a carne bianca: risultati preliminari. Atti S.I.S. Vet., LVIII, 130.
- Fink-Gremmels J. (2008). Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences. Eur J Pharmacol 585:502–9.
- Giantin M, Carletti M, Capolongo F, Pegolo S, Lopparelli RM, Gusson F, Nebbia C, Cantiello M, Martin P, Pineau T, Dacasto M. (2008). Effect of breed upon cytochrome P450 and phase II enzyme expression in cattle liver. Drug Metab Disposit 36:885–93.
- Gonzalez FJ. (1992). Human cytochromes P450: problems and prospects. Trend Pharmacol Sci 13:346–52.
- Guengerich FP. (1996). In vitro techniques for studying drug metabolism. J Pharmacokinet Biopharmaceut 24:521–33.
- Guo LQ, Taniguchi M, Xiao YQ, Baba K, Ohta T, Yamazoe Y. (2000). Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol 82:122–9.
- Guo Z, Raeissi S, White RB, Stevens JC. (1997). Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab Disposit 25:390–3.
- Ioannides C. (2006). Cytochrome P450 expression in the liver of food-producing animals. Curr Drug Metab 7:335–48.
- Lowry OH, Rosenbrough NY, Farr AL, Randall RY. (1951), Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75.
- Nakamura A, Yamamoto Y, Tasaki T, Sugimoto C, Masuda M, Kazusaka A, Fujita S. (1995). Anti-peptide antibodies to the P4502D subfamily in rat, dog and man. Xenobiotica 25:1103–9.
- Northrop DB. (1998). On the meaning of KM and V/K. J Chem Educat 75:1153–7.
- Peffer RC, Moggs JG, Pastoor T, Currie RA, Wright J, Milburn G, Waechter F, Rusynm I. (2007). Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicol Sci 99:315–25.
- Pegolo S, Merlanti R, Giantin M, Dacasto M, Montesissa C, Capolongo F. (2010). High performance liquid chromatography determination of cytochrome P450 1A and 2C activities in bovine liver microsomes. Vet J 183:81–8.
- Reidy GF, Mehta I, Murray M. (1989). Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozymespecific complexation of cytochrome P-450 and inhibition kinetics. Mol Pharmacol 35:736–43.
- Roberts ES, Hopkins EN, Foroozesh M, Alworth WL, Halpert JR, Hollenberg PF. (1997). Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes. Drug Metab Disposit 25:1242–8.
- Sivapathasundaram S, Magnisali P, Coldham NG, Howells LC, Sauer MJ, Ioannides C. (2001). A study of the expression of the xenobiotic-metabolizing cytochrome P450 proteins and of testosterone metabolism in bovine liver. Biochem Pharmacol 62:635–45.
- Skaanild MT, Friis C. (2002). Is cytochrome P450 CYP2D activity present in pig liver? Pharmacol Toxicol 91:198–203.
- Szotáková B, Baliharová V, Lamka J, Nozinová E, Wsól V, Velík J, Machala M, Neca J, Soucek P, Susová S, Skálová L. (2004). Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Res Vet Sci 76:43–51.
- Wang RW, Lu AYH. (1997). Inhibitory anti-peptide antibody against human CYP3A4. Drug Metab Disposit 25:762–7.
- Zweers-Zeilmaker WM, van Miert ASJPAM, Horbach GJ, Witkamp RF. (1998). In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle. Res Vet Sci 66:51–5.